Literature DB >> 8409038

Myocardial risk area defined by technetium-99m sestamibi imaging during percutaneous transluminal coronary angioplasty: comparison with coronary angiography.

H L Haronian1, M S Remetz, A J Sinusas, J M Baron, H I Miller, M W Cleman, B L Zaret, F J Wackers.   

Abstract

OBJECTIVES: The purpose of this study was to compare the assessment of myocardial area at risk in patients with coronary artery stenosis by coronary angiography and quantitative myocardial perfusion imaging with technetium-99m sestamibi.
BACKGROUND: Decisions concerning patient management frequently rely on semiquantitative angiographic estimation of the myocardial area at risk, although this approach has not been well validated. Technetium-99m sestamibi is a perfusion imaging agent with little redistribution after initial myocardial uptake. This characteristic allows for injection during angioplasty and later imaging for visualization and quantitation of the nonperfused area at risk.
METHODS: Thirty-nine patients referred for coronary angioplasty were studied. Technetium-99m sestamibi was injected intravenously during angioplasty balloon inflation. Planar (33 patients) or tomographic (6 patients) imaging was performed after completion of angioplasty. Imaging was repeated 24 to 48 h later. Myocardial risk area (perfusion defect on angioplasty image) was quantified as an integral using circumferential count distribution profiles and normal reference. Angiographic risk area was assessed using five scoring methods.
RESULTS: The scintigraphic risk area was 14 +/- 15 on planar images and 39 +/- 16 on tomography. Scintigraphic risk area of patients with infarction was larger than in patients without (22 +/- 17 versus 7 +/- 8, p = 0.003). The left anterior descending coronary artery had a larger mean risk area than other vessels (22 +/- 15 versus 7 +/- 11, p = 0.002). The presence of angiographic collateral channels was associated with smaller risk areas. Angiographic risk scores correlated only moderately with the technetium-99m sestamibi risk area (r = 0.54 to 0.65), with considerable spread of data.
CONCLUSIONS: Area at risk estimated from coronary angiography does not correlate well with that from quantitative myocardial perfusion imaging with technetium-99m sestamibi. These findings emphasize that the functional significance of coronary artery disease is not predicted by coronary anatomy alone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409038     DOI: 10.1016/0735-1097(93)90413-u

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Nuclear cardiology: the interventionalists' perspective.

Authors:  H L Haronian; H S Cabin
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

2.  Quantitative comparison of single-isotope and dual-isotope stress-rest single-photon emission computed tomographic imaging for reversibility of defects.

Authors:  H M Siebelink; D Natale; A J Sinusas; F J Wackers
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

3.  Residual area at risk after anterior myocardial infarction: are ST segment changes during coronary angioplasty a reliable indicator? A comparison with technetium 99m-labeled sestamibi single-photon emission computed tomography.

Authors:  M Faraggi; P G Steg; D Francois; L Sarda; J M Foult; D Daou; P Assayag; D Le Guludec
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

4.  Quantification of myocardial area at risk in the absence of collateral flow: the validation of angiographic scores by myocardial perfusion single-photon emission computed tomography.

Authors:  José F Rodríguez-Palomares; Albert Alonso; Gerard Martí; Santiago Aguadé-Bruix; M T González-Alujas; Guillermo Romero-Farina; Jaume Candell-Riera; Bruno García del Blanco; Artur Evangelista; David García-Dorado
Journal:  J Nucl Cardiol       Date:  2012-11-10       Impact factor: 5.952

5.  Resolution of ST-segment elevation after streptokinase therapy in anterior versus inferior wall myocardial infarction.

Authors:  E Guzman; I A Khan; S I Rahmatullah; C Verghese; K S Yi; A P Niarchos; A W Ansari; R A Cohen
Journal:  Clin Cardiol       Date:  2000-07       Impact factor: 2.882

6.  One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging.

Authors:  K Raiker; A J Sinusas; F J Wackers; B L Zaret
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

7.  Selective intracoronary injection of sestamibi to detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty.

Authors:  Carlo Trani; Alessandro Giordano; Antonella Lombardo; Alessandro Lupi; Francesca Reale; Roberto Patrizi; Giampiero Patrizi; Mario A Mazzari; Giovanni Schiavoni; Attilio Maseri
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.